Regina Silva Paradela
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Regina Silva Paradela has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Claudia Kimie Suemoto
University of São Paulo Medical School, São Paulo, São Paulo Brazil
4 shared publicationsCarlos A. Pasqualucci
Department of Pathology, University of Sao Paulo Medical School, Sao Paulo, Brazil
3 shared publicationsLea T. Grinberg
Memory and Aging Center, University of California, San Francisco, USA
3 shared publicationsMayana Zatz
Human Genome and Stem Cell Center, Biosciences Institute, University of São Paulo, São Paulo, Brazil
3 shared publicationsMichel Satya Naslavsky
Human Genome and Stem Cell Center, Biosciences Institute, University of São Paulo, São Paulo, Brazil
3 shared publicationsRicardo Nitrini
Department of Neurology, University of São Paulo Medical School, São Paulo, Brazil
3 shared publications
Latest Publications
- 26 June 2025
- Published by Elsevier in Neuroscience
- Vol. 581, 95-103
Cogmed cognitive training for working memory: a systematic review and meta-analysis
- 26 June 2025
- Published by Elsevier in Neuroscience
- Vol. 581, 95-103
Cogmed cognitive training for working memory: a systematic review and meta-analysis
- Open Access
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Population Attributable Fractions for Risk Factors for Dementia in Latin America
Background: Approximately 40% of global dementia cases are associated with 12 modifiable risk factors (less education, hearing loss, hypertension, obesity, smoking, depression, social isolation, physical inactivity, diabetes, alcohol excess, air pollution, and traumatic brain injury). However, the number of people with these risk factors differs between populations. Latin American countries differ in socioeconomic and geographic aspects and, therefore, risk factors prevalence. Our goal was to determine the population‐attributable fraction (PAF) of these risk factors (combined and individually) for dementia by analyzing population‐based samples from seven countries in Latin America (LA).Method: We used data from Argentinian, Brazilian, Bolivian, Chilean, Honduran, Mexican, and Peruvian cross‐sectional, nationally representative surveys with harmonized measurements of the 12 modifiable risk factors for dementia. Data were collected between 2015 and 2021, and the survey sample size varied from 5,995 to 107,907 participants aged 18 years or older across the seven countries. We calculated the risk factor prevalence and their communalities in each country and used these with relative risks for dementia from previous meta‐analyses to calculate the PAFs. Pooled PAFs for LA were then obtained using random effect meta‐analyses.Result: The overall proportion of dementia cases attributed to 12 modifiable risk factors varied across LA countries (62% in Chile, 60% in Argentina, 56% in Bolivia, 56% in Mexico, 54% in Honduras, 48% in Brazil, and 45% in Peru), with an overall PAF of 54% for LA (95% CI 48.8‐59.6). Obesity (weighted PAF = 7%), physical inactivity (weighted PAF = 6%), and depression (weighted PAF = 5%) had the highest PAFs in LA.Conclusion: There is potential for prevention of a higher proportion of dementia in LA than worldwide. Obesity, physical inactivity, and depression are the major contributors to dementia variance across the seven LA countries. These findings have implications for dementia prevention strategies in LA.
- 1 December 2024
- Published by Wiley in Alzheimer's & Dementia
- Vol. 20 (S7)
Open AccessPopulation Attributable Fractions for Risk Factors for Dementia in Latin America
Background: Approximately 40% of global dementia cases are associated with 12 modifiable risk factors (less education, hearing loss, hypertension, obesity, smoking, depression, social isolation, physical inactivity, diabetes, alcohol excess, air pollution, and traumatic brain injury). However, the number of people with these risk factors differs between populations. Latin American countries differ in socioeconomic and geographic aspects and, therefore, risk factors prevalence. Our goal was to determine the population‐attributable fraction (PAF) of these risk factors (combined and individually) for dementia by analyzing population‐based samples from seven countries in Latin America (LA).Method: We used data from Argentinian, Brazilian, Bolivian, Chilean, Honduran, Mexican, and Peruvian cross‐sectional, nationally representative surveys with harmonized measurements of the 12 modifiable risk factors for dementia. Data were collected between 2015 and 2021, and the survey sample size varied from 5,995 to 107,907 participants aged 18 years or older across the seven countries. We calculated the risk factor prevalence and their communalities in each country and used these with relative risks for dementia from previous meta‐analyses to calculate the PAFs. Pooled PAFs for LA were then obtained using random effect meta‐analyses.Result: The overall proportion of dementia cases attributed to 12 modifiable risk factors varied across LA countries (62% in Chile, 60% in Argentina, 56% in Bolivia, 56% in Mexico, 54% in Honduras, 48% in Brazil, and 45% in Peru), with an overall PAF of 54% for LA (95% CI 48.8‐59.6). Obesity (weighted PAF = 7%), physical inactivity (weighted PAF = 6%), and depression (weighted PAF = 5%) had the highest PAFs in LA.Conclusion: There is potential for prevention of a higher proportion of dementia in LA than worldwide. Obesity, physical inactivity, and depression are the major contributors to dementia variance across the seven LA countries. These findings have implications for dementia prevention strategies in LA.
- Open Access
- 10 October 2024
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 16 (4) , e70017
Hospital admissions for dementia in the Brazilian public health system over the last decade
OBJECTIVE: The rise in dementia prevalence, particularly in lower‐ and middle‐income countries (LMIC), places a significant burden on healthcare systems. However, comprehensive data on dementia hospital admissions are scarce.METHODS: We analyzed admission rates for dementia, cost of hospital admissions, lengths of hospital stay, and in‐hospital deaths in 2010 and 2019 in Brazil.RESULTS: Admission rates declined from 19.7/100,000 inhabitants in 2010 to 14.6/100,000 in 2019. In‐hospital mortality increased from 3.9% in 2010 to 8.8% in 2019, particularly for short‐term stays. Although 9.6% of hospital admissions occurred in regions with lower economic power in 2010 and 10.4% in 2019, these regions had higher mortality, reaching 4.3% of in‐hospital deaths in 2010 and 9.3% in 2019.CONCLUSION: The observed trends, alongside sex and regional disparities, underscore the need for targeted investment in healthcare infrastructure and training to improve dementia care in LMIC.Highlights: The rate of hospital admissions for dementia was similar in 2010 and 2019 in Brazil. The cost per hospital admission in 2010 decreased by 38.5% compared with 2019. There was an increase in short‐term hospital stays for dementia in 2019 compared to 2010, accompanied by an increase in mortality rates for these short‐term stays. While hospital admissions for dementia decreased in men and increased in women, the in‐hospital mortality due to dementia increased for both sexes.
- 10 October 2024
- Published by Wiley in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
- Vol. 16 (4) , e70017
Open AccessHospital admissions for dementia in the Brazilian public health system over the last decade
OBJECTIVE: The rise in dementia prevalence, particularly in lower‐ and middle‐income countries (LMIC), places a significant burden on healthcare systems. However, comprehensive data on dementia hospital admissions are scarce.METHODS: We analyzed admission rates for dementia, cost of hospital admissions, lengths of hospital stay, and in‐hospital deaths in 2010 and 2019 in Brazil.RESULTS: Admission rates declined from 19.7/100,000 inhabitants in 2010 to 14.6/100,000 in 2019. In‐hospital mortality increased from 3.9% in 2010 to 8.8% in 2019, particularly for short‐term stays. Although 9.6% of hospital admissions occurred in regions with lower economic power in 2010 and 10.4% in 2019, these regions had higher mortality, reaching 4.3% of in‐hospital deaths in 2010 and 9.3% in 2019.CONCLUSION: The observed trends, alongside sex and regional disparities, underscore the need for targeted investment in healthcare infrastructure and training to improve dementia care in LMIC.Highlights: The rate of hospital admissions for dementia was similar in 2010 and 2019 in Brazil. The cost per hospital admission in 2010 decreased by 38.5% compared with 2019. There was an increase in short‐term hospital stays for dementia in 2019 compared to 2010, accompanied by an increase in mortality rates for these short‐term stays. While hospital admissions for dementia decreased in men and increased in women, the in‐hospital mortality due to dementia increased for both sexes.
- Open Access
- 19 December 2023
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 11 (1) , 1-10
Association between APOE-ε4 allele and cognitive function is mediated by Alzheimer’s disease pathology: a population-based autopsy study in an admixed sample
Background: Apolipoprotein E ε4 allele (APOE-ε4) is the main genetic risk factor for late-onset Alzheimer’s disease (AD) and may impact cognitive function also via other neuropathological lesions. However, there is limited evidence available from diverse populations, as APOE associations with dementia seem to differ by race. Therefore, we aimed to evaluate the pathways linking APOE-ε4 to cognitive abilities through AD and non-AD neuropathology in an autopsy study with an admixed sample. Methods: Neuropathological lesions were evaluated following international criteria using immunohistochemistry. Participants were classified into APOE-ε4 carriers (at least one ε4 allele) and non-carriers. Cognitive abilities were evaluated by the Clinical Dementia Rating Scale sum of boxes. Mediation analyses were conducted to assess the indirect association of APOE-ε4 with cognition through AD-pathology, lacunar infarcts, hyaline arteriosclerosis, cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), and TAR DNA-binding protein 43 (TDP-43). Results: We included 648 participants (mean age 75 ± 12 years old, mean education 4.4 ± 3.7 years, 52% women, 69% White, and 28% APOE-ε4 carriers). The association between APOE-ε4 and cognitive abilities was mediated by neurofibrillary tangles (β = 0.88, 95% CI = 0.45; 1.38, p < 0.001) and neuritic plaques (β = 1.36, 95% CI = 0.86; 1.96, p < 0.001). Lacunar infarcts, hyaline arteriosclerosis, CAA, LBD, and TDP-43 were not mediators in the pathway from APOE-ε4 to cognition. Conclusion: The association between APOE-ε4 and cognitive abilities was partially mediated by AD-pathology. On the other hand, cerebrovascular lesions and other neurodegenerative diseases did not mediate the association between APOE-ε4 and cognition.
- 19 December 2023
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 11 (1) , 1-10
Open AccessAssociation between APOE-ε4 allele and cognitive function is mediated by Alzheimer’s disease pathology: a population-based autopsy study in an admixed sample
Background: Apolipoprotein E ε4 allele (APOE-ε4) is the main genetic risk factor for late-onset Alzheimer’s disease (AD) and may impact cognitive function also via other neuropathological lesions. However, there is limited evidence available from diverse populations, as APOE associations with dementia seem to differ by race. Therefore, we aimed to evaluate the pathways linking APOE-ε4 to cognitive abilities through AD and non-AD neuropathology in an autopsy study with an admixed sample. Methods: Neuropathological lesions were evaluated following international criteria using immunohistochemistry. Participants were classified into APOE-ε4 carriers (at least one ε4 allele) and non-carriers. Cognitive abilities were evaluated by the Clinical Dementia Rating Scale sum of boxes. Mediation analyses were conducted to assess the indirect association of APOE-ε4 with cognition through AD-pathology, lacunar infarcts, hyaline arteriosclerosis, cerebral amyloid angiopathy (CAA), Lewy body disease (LBD), and TAR DNA-binding protein 43 (TDP-43). Results: We included 648 participants (mean age 75 ± 12 years old, mean education 4.4 ± 3.7 years, 52% women, 69% White, and 28% APOE-ε4 carriers). The association between APOE-ε4 and cognitive abilities was mediated by neurofibrillary tangles (β = 0.88, 95% CI = 0.45; 1.38, p < 0.001) and neuritic plaques (β = 1.36, 95% CI = 0.86; 1.96, p < 0.001). Lacunar infarcts, hyaline arteriosclerosis, CAA, LBD, and TDP-43 were not mediators in the pathway from APOE-ε4 to cognition. Conclusion: The association between APOE-ε4 and cognitive abilities was partially mediated by AD-pathology. On the other hand, cerebrovascular lesions and other neurodegenerative diseases did not mediate the association between APOE-ε4 and cognition.
- 31 July 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (9) , 107229
Apolipoprotein E ε2 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study
- 31 July 2023
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 32 (9) , 107229
Apolipoprotein E ε2 allele is associated with lower risk of carotid artery obstruction in a population-based autopsy study
- Open Access
- 7 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1185768
Computerized working memory training for hypertensive individuals with executive function impairment: a randomized clinical trial
Background: Hypertension is associated with working memory (WM) impairment. However, the benefits of Cogmed WM training for the hypertensive population are unknown. Therefore, we aimed to evaluate Cogmed’s effects on the WM performance of hypertensive individuals with executive function (EF) impairment.Methods: We included 40 hypertensive patients (aged 40–70 years, 68% female) with EF impairment. They were randomized in a 1:1 ratio to receive 10 weeks of adaptive Cogmed training or a non-adaptive control training based on online games. The primary outcome was the WM performance. The secondary outcomes were verbal memory, visuospatial ability, executive function, global cognition, and the neuronal activity measured using functional magnetic resonance imaging (fMRI) under two WM task conditions: low (memorization of 4 spatial locations) and high (memorization of 6 spatial locations). An intention-to-treat (ITT) and per-protocol (PP) analysis were performed.Results: Cogmed did not show a significant effect on WM or any other cognitive outcome post-training. However, under the WM-low load and WM-high load conditions of the fMRI, respectively, the Cogmed group had an activation decrease in the right superior parietal lobe (ITT and PP analyses) and left inferior frontal lobe (PP analysis) in comparison to the control group.Conclusion: The Cogmed showed no effects on the WM performance of hypertensive individuals with EF impairment. However, activation decreases were observed in frontoparietal areas related to the WM network, suggesting a more efficient neuronal activity after training.
- 7 July 2023
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 17, 1185768
Open AccessComputerized working memory training for hypertensive individuals with executive function impairment: a randomized clinical trial
Background: Hypertension is associated with working memory (WM) impairment. However, the benefits of Cogmed WM training for the hypertensive population are unknown. Therefore, we aimed to evaluate Cogmed’s effects on the WM performance of hypertensive individuals with executive function (EF) impairment.Methods: We included 40 hypertensive patients (aged 40–70 years, 68% female) with EF impairment. They were randomized in a 1:1 ratio to receive 10 weeks of adaptive Cogmed training or a non-adaptive control training based on online games. The primary outcome was the WM performance. The secondary outcomes were verbal memory, visuospatial ability, executive function, global cognition, and the neuronal activity measured using functional magnetic resonance imaging (fMRI) under two WM task conditions: low (memorization of 4 spatial locations) and high (memorization of 6 spatial locations). An intention-to-treat (ITT) and per-protocol (PP) analysis were performed.Results: Cogmed did not show a significant effect on WM or any other cognitive outcome post-training. However, under the WM-low load and WM-high load conditions of the fMRI, respectively, the Cogmed group had an activation decrease in the right superior parietal lobe (ITT and PP analyses) and left inferior frontal lobe (PP analysis) in comparison to the control group.Conclusion: The Cogmed showed no effects on the WM performance of hypertensive individuals with EF impairment. However, activation decreases were observed in frontoparietal areas related to the WM network, suggesting a more efficient neuronal activity after training.
- 23 September 2022
- Published by Elsevier in Cardiovascular Pathology
- Vol. 62, 107479
Apolipoprotein E genotypes were not associated with intracranial atherosclerosis: a population-based autopsy study
- 23 September 2022
- Published by Elsevier in Cardiovascular Pathology
- Vol. 62, 107479
Apolipoprotein E genotypes were not associated with intracranial atherosclerosis: a population-based autopsy study